BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL

logo

  Paul-Ehrlich-Strasse 51-59 – Langen – 63225

  VAT: nan

   http://www.pei.de


Complicit EU Projects


  Within the Horizon 2020 (2014-2020) framework, BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL has received € 570,413.0 for its participation in a total of 2 project(s) with a total cost of € 30,039,006.
Start
YYYYMMDD
End
YYYYMMDD
Project ID Project Name Themes Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2021-03-01 2025-02-28 955575 T-OP proteins  ·  oncology  ·  immunotherapy  ·  cells technologies participant € 252,788.4 € 4,100,958 1 12 CORDIS ↪
2019-11-01 2023-04-30 853966 EU-PEARL governance  ·  tuberculosis participant € 317,625.0 € 25,938,047 1 41 CORDIS ↪

  Within the Horizon Europe (2021-2027) framework, BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL has received € 128,534.0 for its participation in a total of 1 project(s) with a total cost of € 145,830,619.
Start
YYYYMMDD
End
YYYYMMDD
Project ID Project Name Themes Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2024-09-01 2031-08-31 101156595 ERDERA ecosystems participant € 128,534.69 € 145,830,619 2 178 CORDIS ↪

  Within the FP7 (2007-2013) framework, BUNDESINSTITUT FUR IMPFSTOFFE UND BIOMEDIZINISCHE ARZNEIMITTEL has received € 633,868.0 for its participation in a total of 1 project(s) with a total cost of € 32,851,056.
Start
YYYYMMDD
End
YYYYMMDD
Project ID Project Name Themes Role EC Contribution Total Cost IL Participation Total Participation CORDIS Link
2012-03-01 2018-02-28 115303 ABIRISK rheumatology  ·  databases  ·  immunisation  ·  multiple sclerosis  ·  gastroenterology participant € 633,868.0 € 32,851,056 2 38 CORDIS ↪